Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Optic Neuritis, its Differential Diagnosis and Management.
Neuroradiological evaluation of demyelinating disease.
Fibrinogen: A Circulating Factor in Search for Its Genetic Architecture.
[Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis.]
Colour vision impairment is associated with disease severity in multiple sclerosis.
Long-term efficacy of Gilenya® reinforced by new 'no evidence of disease activity' (NEDA-4) analysis in MS patients over seven years
NAD(+) protects against EAE by regulating CD4(+) T-cell differentiation.
Requirement for interleukin-1 to drive brain inflammation reveals tissue-specific mechanisms of innate immunity.
Dual Inhibition of IL-23 and IL-17 Offers Superior Efficacy in Mouse Models of Autoimmunity.
Virtual rehabilitation for multiple sclerosis using a kinect-based system: randomized controlled trial.
Abnormal control of orbicularis oculi reflex excitability in multiple sclerosis.
Using Observational Analysis of Multiple Sclerosis Relapse to Design Outcomes-Based Contracts for Disease-Modifying Drugs: A Feasibility Assessment.
A new model for primary-progressive multiple sclerosis?
Concurrent Quantification of Tryptophan and Its Major Metabolites.
Guillain-Barré syndrome: subtypes and predictors of outcome from India.
Cortical remyelination: A new target for repair therapies in multiple sclerosis.
Chronic pain in episodic illness and its influence on work occupations: A scoping review.
On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica.
Anti-aquaporin-4 IgG in Patients Presenting with Unilateral Optic Neuritis: A Cohort Study.
Peptidylarginine deiminase and protein citrullination in prion diseases: Strong evidence of neurodegeneration.
The miR-30a Negatively Regulates IL-17-Mediated Signal Transduction by Targeting Traf3ip2.
Targeting Dynamic Balance in Falls-Prevention Interventions in Multiple Sclerosis: Recommendations from the International MS Falls Prevention Research Network.
Intrinsic Functional Plasticity of the Sensorimotor Network in Relapsing-Remitting Multiple Sclerosis: Evidence from a Centrality Analysis.
Polyomavirus JC infection inhibits differentiation of oligodendrocyte progenitor cells.
[An update on the treatment options for multiple sclerosis].
Pages
« first
‹ previous
…
336
337
338
339
340
341
342
343
344
…
next ›
last »